Search for Clinical Trial Results
Anaplastic Astrocytoma - 216 Studies Found
| Status | Study |
| Completed |
Study Name: Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma Condition:
Date: 2006-06-06 Interventions:
|
| Completed |
Study Name: TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Condition:
|
| Completed |
Study Name: Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children Condition:
Date: 2016-08-24 Interventions: Drug: Cabozantinib Subjects will receive Cabozantinib |
| Completed |
Study Name: Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly Condition:
Date: 2011-12-24 Interventions:
|
| Terminated |
Study Name: Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy Condition:
|
| Terminated |
Study Name: A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma Condition:
|
| Completed |
Study Name: AMG 595 First-in-Human in Recurrent Gliomas Condition:
Interventions: Drug: AMG 595 AMG 595 is an antibody drug conjugate that binds to EGFRvIII. |